Literature DB >> 24049710

Take Two Iron Chelators and Call Me in the Morning.

Steven J Fliesler1.   

Abstract

Entities:  

Year:  2012        PMID： 24049710      PMCID： PMC3763883          DOI： 10.1167/tvst.1.3.2a

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN： 2164-2591            Impact factor:   3.283


× No keyword cloud information.
  4 in total

1.  Thalassaemia major: the murky story of deferiprone.

Authors:  Julian Savulescu
Journal:  BMJ       Date:  2004-02-14

2.  The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration.

Authors:  Majda Hadziahmetovic; Ying Song; Natalie Wolkow; Jared Iacovelli; Steven Grieco; Jennifer Lee; Arkady Lyubarsky; Domenico Pratico; John Connelly; Michael Spino; Z Leah Harris; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-16       Impact factor: 4.799

3.  Orally active multi-functional antioxidants are neuroprotective in a rat model of light-induced retinal damage.

Authors:  James Randazzo; Zifeng Zhang; Michael Hoff; Hiroyoshi Kawada; Andrew Sachs; Yang Yuan; Neena Haider; Peter Kador
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

4.  The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse Mechanisms.

Authors:  Majda Hadziahmetovic; Miroslav Pajic; Steven Grieco; Ying Song; Delu Song; Yafeng Li; Alyssa Cwanger; Jared Iacovelli; Sally Chu; Gui-Shuang Ying; John Connelly; Michael Spino; Joshua L Dunaief
Journal:  Transl Vis Sci Technol       Date:  2012-10-25       Impact factor: 3.283
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.